C. Angerstein

649 total citations
14 papers, 432 citations indexed

About

C. Angerstein is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, C. Angerstein has authored 14 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in C. Angerstein's work include Radiopharmaceutical Chemistry and Applications (7 papers), Neuroendocrine Tumor Research Advances (6 papers) and Lung Cancer Research Studies (6 papers). C. Angerstein is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (7 papers), Neuroendocrine Tumor Research Advances (6 papers) and Lung Cancer Research Studies (6 papers). C. Angerstein collaborates with scholars based in Germany, United States and Czechia. C. Angerstein's co-authors include Thomas M. Behr, Martin Béhé, Wolfgang Becker, S. Gratz, Friedhelm Raue, George Sgouros, Klaus Nebendahl, Martin Gotthardt, W. Becker and Robert H. Mach and has published in prestigious journals such as European Journal of Nuclear Medicine and Molecular Imaging, Medical Oncology and Nuclear Medicine Communications.

In The Last Decade

C. Angerstein

14 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Angerstein Germany 8 290 191 183 93 47 14 432
Marcel E. van der Pluijm Netherlands 7 321 1.1× 308 1.6× 261 1.4× 70 0.8× 45 1.0× 8 506
M. de Jong Netherlands 8 271 0.9× 305 1.6× 278 1.5× 56 0.6× 68 1.4× 10 549
E. Havlik Austria 11 161 0.6× 163 0.9× 131 0.7× 37 0.4× 63 1.3× 32 419
Luigi Del Pozzo Switzerland 10 391 1.3× 325 1.7× 354 1.9× 98 1.1× 66 1.4× 17 629
Stefano Papi Italy 10 182 0.6× 179 0.9× 193 1.1× 49 0.5× 47 1.0× 25 446
Thomas Pangerl Austria 11 162 0.6× 284 1.5× 220 1.2× 61 0.7× 59 1.3× 14 446
Ho Sze Chan Netherlands 14 474 1.6× 209 1.1× 230 1.3× 177 1.9× 51 1.1× 19 631
A. A. Razbash Germany 3 311 1.1× 161 0.8× 171 0.9× 119 1.3× 32 0.7× 5 432
Maria‐Luisa Tamma Switzerland 12 379 1.3× 284 1.5× 356 1.9× 126 1.4× 117 2.5× 14 641
Arthur van Gameren Netherlands 11 435 1.5× 447 2.3× 380 2.1× 79 0.8× 57 1.2× 14 711

Countries citing papers authored by C. Angerstein

Since Specialization
Citations

This map shows the geographic impact of C. Angerstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Angerstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Angerstein more than expected).

Fields of papers citing papers by C. Angerstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Angerstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Angerstein. The network helps show where C. Angerstein may publish in the future.

Co-authorship network of co-authors of C. Angerstein

This figure shows the co-authorship network connecting the top 25 collaborators of C. Angerstein. A scholar is included among the top collaborators of C. Angerstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Angerstein. C. Angerstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Angerstein, C., U. Siefker, Kurt Lehmann, et al.. (2003). Clinical evaluation of a new thyroglobulin immunoradiometric assay in the follow-up of differentiated thyroid carcinoma. Nuklearmedizin - NuclearMedicine. 42(2). 71–77. 4 indexed citations
3.
Holmberg, Anders, Martin Béhé, Jin Du, et al.. (2001). Biodistribution, Blood Half-Life, and Receptor Binding of a Somatostatin-Dextran Conjugate. Medical Oncology. 18(1). 59–64. 18 indexed citations
4.
Lehmann, K., C. Angerstein, J. Meller, Martin Béhé, & William H. Becker. (2001). 17. The basis of 18F-FDG scintigraphy for imaging infection. Nuclear Medicine Communications. 22(10). 1157–1158. 1 indexed citations
5.
Gratz, S., Martin Béhé, Otto C. Boerman, et al.. (2001). 99mTc-E-selectin binding peptide for imaging acute osteomyelitis in a novel rat model. Nuclear Medicine Communications. 22(9). 1003–1013. 11 indexed citations
6.
Behr, Thomas M., Martin Béhé, George Sgouros, et al.. (2000). Therapeutic advantages of Auger electron- over β-emitting radiometals or radioiodine when conjugated to internalizing antibodies. European Journal of Nuclear Medicine and Molecular Imaging. 27(7). 753–765. 86 indexed citations
7.
8.
9.
Béhé, Martin, Thomas M. Behr, C. Angerstein, & W. Becker. (2000). Stabilized DTPA chelator as an alternative to the DOTA chelator exemplified with minigastrin. Nuclear Medicine Communications. 21(6). 564–564. 4 indexed citations
10.
Behr, Thomas M., Martin Béhé, C. Angerstein, et al.. (2000). Development of cholecystokinin-B (CCK-B)/gastrin-receptor binding peptides: Preclinical evaluation of their diagnostic and therapeutic potential. Nuclear Medicine Communications. 21(6). 584–584. 3 indexed citations
11.
Behr, Thomas M., Martin Béhé, C. Angerstein, et al.. (1999). Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.. PubMed. 40(6). 1029–44. 119 indexed citations
12.
Behr, Thomas M., George Sgouros, Michael G. Stabin, et al.. (1999). Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.. PubMed. 5(10 Suppl). 3031s–3043s. 27 indexed citations
13.
Behr, Thomas M., Torsten Liersch, Martin Béhé, et al.. (1999). Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study.. PubMed. 5(10 Suppl). 3232s–3242s. 42 indexed citations
14.
Behr, Thomas M., Martin Béhé, C. Angerstein, et al.. (1999). Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.. PubMed. 5(10 Suppl). 3124s–3138s. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcel E. van der Pluijm Breakdown of academic impact, for papers by M. de Jong Breakdown of academic impact, for papers by E. Havlik Breakdown of academic impact, for papers by Luigi Del Pozzo Breakdown of academic impact, for papers by Stefano Papi Breakdown of academic impact, for papers by Thomas Pangerl Breakdown of academic impact, for papers by Ho Sze Chan Breakdown of academic impact, for papers by A. A. Razbash Breakdown of academic impact, for papers by Maria‐Luisa Tamma Breakdown of academic impact, for papers by Arthur van Gameren
Rankless by CCL
2026